By proceeding, you agree to our Terms of Use and Privacy Policy.
Elicera Therapeutics is a clinical stage cell and gene therapy company focusing on immunooncology.
22-23 August 2022
The current generation of CAR-T approaches for hematological malignancies generate strong responses in cancer patients, but too often progression-free survival is less than 12 months. The next-generation allogeneic approaches may make these therapies
Event Ended
USA
Paid
Boston